About mesa lab - MLAB
Mesa Laboratories, Inc. engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. The Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators. The Clinical Genomics segment division develops, manufactures and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables and services that enable clinical research labs and contract research organizations. The Biopharmaceutical Development segment caters and sells automated systems for protein analysis and peptide synthesis solutions. The Calibration Solutions segment focuses on the quality control products using principles of advanced metrology to enable customers to measure and calibrate critical parameters in applications such as renal care, environmental and process monitoring, gas flow, air quality and torque testing, primarily in medical device manufacturing, pharmaceutical manufacturing, laboratory and hospital environments. The company was founded by Luke R. Schmieder on March 26, 1982 and is headquartered in Lakewood, CO.
MLAB At a Glance
Mesa Laboratories, Inc.
12100 West 6th Avenue
Lakewood, Colorado 80228
| Phone | 1-303-987-8000 | | Revenue | 249.13M |
| Industry | Medical Specialties | | Net Income | 6.71M |
| Sector | Health Technology | | 2026 Sales Growth | 3.383% |
| Fiscal Year-end | 03 / 2027 | | Employees | 717 |
|
View SEC Filings
| | | | |
MLAB Valuation
| P/E Current | 151.183 |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | 73.311 |
| Price to Sales Ratio | 1.975 |
| Price to Book Ratio | 2.623 |
| Price to Cash Flow Ratio | 11.49 |
| Enterprise Value to EBITDA | 15.173 |
| Enterprise Value to Sales | 2.545 |
| Total Debt to Enterprise Value | 0.266 |
MLAB Efficiency
| Revenue/Employee | 347,461.646 |
| Income Per Employee | 9,361.227 |
| Receivables Turnover | 5.649 |
| Total Asset Turnover | 0.579 |
MLAB Liquidity
| Current Ratio | 1.717 |
| Quick Ratio | 1.291 |
| Cash Ratio | 0.435 |
MLAB Profitability
| Gross Margin | 56.563 |
| Operating Margin | 7.43 |
| Pretax Margin | 4.822 |
| Net Margin | 2.694 |
| Return on Assets | 1.559 |
| Return on Equity | 3.879 |
| Return on Total Capital | 1.89 |
| Return on Invested Capital | 2.257 |
MLAB Capital Structure
| Total Debt to Total Equity | 90.65 |
| Total Debt to Total Capital | 47.548 |
| Total Debt to Total Assets | 39.47 |
| Long-Term Debt to Equity | 85.65 |
| Long-Term Debt to Total Capital | 44.925 |